ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02969525
Brief Title: A Multicenter Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis.

First Submitted : November 10, 2016
First Submitted that Met QC Criteria : November 16, 2016
First Posted : November 21, 2016 (Estimate)

Certification/Extension First Submitted : November 2, 2018
Certification/Extension First Submitted that Met QC Criteria : November 2, 2018
Certification/Extension First Posted : November 6, 2018

Last Update Submitted that Met QC Criteria : November 2, 2018
Last Update Posted : November 6, 2018